{
 "generic_name": "Atazanavir Sulfate; Cobicistat Tablet",
 "slug": "atazanavir-sulfate-cobicistat-tablet",
 "brand_names": [
  "Evotaz"
 ],
 "fda_status": [
  "To Be Discontinued"
 ],
 "last_fda_update": "11/03/2025",
 "first_posted": "11/03/2025",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Bristol Myers Squibb Co.",
   "package_ndc": "0003-3641-11",
   "presentation": "Evotaz, Tablet, 300 mg; 150 mg (NDC 0003-3641-11)",
   "availability": "Not specified",
   "availability_raw": null,
   "fda_note": "The global Cease Manufacture date for EVOTAZ® currently is estimated to begin April 2026."
  }
 ],
 "changes": []
}